Skip to content
★ Sign in to follow
WR
Total declarations
8
Company
1
▲ Purchases (4 ops.)
€112k
▼ Sales (2 ops.)
€737k

Latest filing published 08 May 2007 for HAEMONETICS CORP, €178k.

Insider track record

Disclosed buys
4
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
4
Positive at T+90
50%
Median T+90
+2.2%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 May 2007 · 7130 days ago · €9,780
    +8.5%
    Entry US$24.80 · Close at T+365 US$26.91
  • Filed 03 Nov 2006 · 7311 days ago · €5,470
    +26.7%
    Entry US$22.55 · Close at T+365 US$28.57
  • Filed 02 May 2006 · 7496 days ago · €10k
    -3.2%
    Entry US$25.78 · Close at T+365 US$24.97
  • Filed 03 Feb 2006 · 7584 days ago · €87k
    -2.3%
    Entry US$24.50 · Close at T+365 US$23.92

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

William Roche Still: trading record in brief

William Roche Still appears in our data through filings on Haemonetics Corp shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 2 February 2006 to 4 May 2007.

Market trades split into 4 purchases (€112k) and 2 sales (€737k). Taken together, the sales exceed the purchases by €625k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. So far in 2007, the count stands at 1 purchase and 2 sales.

The median purchase comes to €10k. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +2.2%. This is a record of the past, not a forecast.

Most recently, on 8 May 2007, the filings show an option exercise worth €178k in Haemonetics Corp. The clock since the last published purchase (3 May 2007) now reads 7,130 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to William Roche Still

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◇
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    242,400 USD0SEC
    10,000 shares@ US$24.24Common StockSEC:0000313143-07-000030:0
  • ▼
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    500,700 USD0SEC
    10,000 shares@ US$50.07Common StockSEC:0000313143-07-000030:1
  • ▲
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    13,289 USD0SEC
    344 shares@ US$38.63Common StockSEC:0000313143-07-000025:0
    Canonical exit: 30 Jul 2007 (T+90)
  • ◇
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    242,400 USD0SEC
    10,000 shares@ US$24.24Common StockSEC:0000313143-07-000010:0
  • ▼
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    477,800 USD0SEC
    10,000 shares@ US$47.78Common StockSEC:0000313143-07-000010:1
  • ▲
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    6,977 USD0SEC
    180 shares@ US$38.76Common StockSEC:0000313143-06-000127:0
    Canonical exit: 30 Jan 2007 (T+90)
  • ▲
    VP & Gen Mrg, Therapeutics BusExecutivesHaemonetics Corp
    12,913 USD0SEC
    311 shares@ US$41.52Common StockSEC:0000313143-06-000032:0
    Canonical exit: 30 Jul 2006 (T+90)
  • ▲
    VP, Strategic Mktg & Bus DevExecutivesHaemonetics Corp
    104,973 USD0SEC
    2,110 shares@ US$49.75Common StockSEC:0000313143-06-000006:0
    Canonical exit: 3 May 2006 (T+90)

8 of 8 declarations